MAPT and Alzheimer disease: The diagnostic characterization of AD disease is the allocation of extracellular amyloid beta (Aβ) forming amyloid plaques and the intracellular compiling of hyper-phosphorylated Tau protein eliciting neurofibrillary tangle formation, leading to neural and glial cell loss [2].